Avita Medical | 1811094D - 应收帐款人



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 185.01M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


应收帐款人 更改 日
Accuray USD 91.79M 7.07M 2024-09
Celltrion KRW 2.01T 39.71B 2026-03
Clinuvel Pharmaceuticals AUD 16.58M 10.88M 2025-12
Cochlear AUD 568.4M 17.5M 2025-12
CSL USD 4.32B 1.35B 2025-12
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Mayne Pharma AUD 193.22M 5.64M 2024-06
Medical Developments International AUD 7.48M 174K 2025-12
Nanosonics AUD 46.45M 8.2M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 53.39M 3.45M 2026-03
Ovoca Bio EUR 39K 408K 2025-06
Pacific Edge NZD 2.46M 1.29M 2026-06
Paradigm Biopharmaceuticals AUD 6.31M 58.85K 2025-12
Pharma Mar EUR 51.19M 9.4M 2026-03
Polynovo AUD 24.21M 945K 2025-12
PYC Therapeutics AUD 32.59M 8.52M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Ramsay Health Care AUD 2.48B 22.3M 2025-12
ResMed USD 1.05B 1.1M 2026-03
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Telix Pharmaceuticals AUD 135.24M 5.72M 2025-12
Tilray USD 109.07M 2M 2025-09
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03